Chemically induced mouse models of acute and chronic intestinal inflammation

Nature Protocols

Volumn 12, Issue 7, 2017, Pages 1295-1309

  Wirtz, Stefan ^a   Popp, Vanessa ^a   Kindermann, Markus ^a   Gerlach, Katharina ^a   Weigmann, Benno ^a   Fichtner Feigl, Stefan ^b   Neurath, Markus F ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DEXTRAN SULFATE; HAPTEN; OXAZOLONE; TRINITROBENZENESULFONIC ACID;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; DISEASE EXACERBATION; EPITHELIUM CELL; EXPERIMENTAL ANIMAL; FEMALE; FIBROSIS; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTERMETHOD COMPARISON; INTESTINE EPITHELIUM; MALE; MOUSE; MOUSE MODEL; NEOPLASM; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; SKILL; T LYMPHOCYTE; ANIMAL; CHEMICALLY INDUCED; CHRONIC DISEASE; DISEASE MODEL; PATHOLOGY;

ANIMALS; CHRONIC DISEASE; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; MICE; OXAZOLONE; TRINITROBENZENESULFONIC ACID;

EID: 85020891738     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2017.044     Document Type: Article

References (57)

1. Danese, S. & Fiocchi, C. Ulcerative colitis. N. Engl. J. Med. 365, 1713-1725 (2011).
2. Baumgart, D.C. & Sandborn, W.J. Crohn's disease. Lancet 380, 1590-1605 (2012).
3. Neurath, M.F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14, 329-342 (2014).
4. Wirtz, S. & Neurath, M.F. Mouse models of inflammatory bowel disease. Adv. Drug Deliv. Rev. 59, 1073-1083 (2007).
5. Saleh, M. & Elson, C.O. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity 34, 293-302 (2011).
6. Strober, W., Fuss, I.J. & Blumberg, R.S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20, 495-549 (2002).
7. Lopez-Posadas, R. et al. Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation. J. Clin. Invest. 126, 611-626 (2016).
8. Perse, M. & Cerar, A. Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012, 718617 (2012).
9. Elson, C.O. et al. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J. Immunol. 157, 2174-2185 (1996).
10. Fiorucci, S. et al. Importance of innate immunity and collagen binding integrin α1β1 in TNBS-induced colitis. Immunity 17, 769-780 (2002).
11. Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E. & Strober, W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182, 1281-1290 (1995).
12. Dohi, T. et al. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J. Exp. Med. 189, 1169-1180 (1999).
13. Kiesler, P., Fuss, I.J. & Strober, W. Experimental models of inflammatory bowel diseases. Cell. Mol. Gastroenterol. Hepatol. 1, 154-170 (2015).
14. Rieder, F., Zimmermann, E.M., Remzi, F.H. & Sandborn, W.J. Crohn's disease complicated by strictures: a systematic review. Gut 62, 1072-1084 (2013).
15. Fichtner-Feigl, S. et al. Induction of IL-13 triggers TGF-β1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J. Immunol. 178, 5859-5870 (2007).
16. Boirivant, M., Fuss, I.J., Chu, A. & Strober, W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188, 1929-1939 (1998).
17. Heller, F., Fuss, I.J., Nieuwenhuis, E.E., Blumberg, R.S. & Strober, W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17, 629-638 (2002).
18. Gerlach, K. et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat. Immunol. 15, 676-686 (2014).
19. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493 (2012).
20. Hoving, J.C. et al. B cells that produce immunoglobulin E mediate colitis in BALB/c mice. Gastroenterology 142, 96-108 (2012).
21. Okayasu, I. et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702 (1990).
22. Laroui, H. et al. Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon. PLoS One 7, e32084 (2012).
23. Hernandez-Chirlaque, C. et al. Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis. J. Crohns Colitis 10, 1324-1335 (2016).
24. Hudcovic, T., Stepankova, R., Cebra, J. & Tlaskalova-Hogenova, H. The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol. 46, 565-572 (2001).
25. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
26. Dieleman, L.A. et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652 (1994).
27. Krieglstein, C.F. et al. Collagen-binding integrin α1β1 regulates intestinal inflammation in experimental colitis. J. Clin. Invest. 110, 1773-1782 (2002).
28. Dieleman, L.A. et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol. 114, 385-391 (1998).
29. Rosen, M.J. et al. Mucosal expression of type 2 and type 17 immune response genes distinguishes ulcerative colitis from colon-only Crohn's disease in treatment-naive pediatric patients. Gastroenterology 152, 1345-1357 (2017).
30. Reinisch, W. et al. Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study. Gut 64, 894-900 (2015).
31. Danese, S. et al. Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study. Gut 64, 243-249 (2015).
32. Engelhardt, K.R. & Grimbacher, B. IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr. Top. Microbiol. Immunol. 380, 1-18 (2014).
33. Kontoyiannis, D., Pasparakis, M., Pizarro, T.T., Cominelli, F. & Kollias, G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10, 387-398 (1999).
34. Pizarro, T.T. et al. SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis. Inflamm. Bowel Dis. 17, 2566-2584 (2011).
35. Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M.F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546 (2007).
36. Mahler, M. et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274, G544-G551 (1998).
37. Bleich, A. & Fox, J.G. The mammalian microbiome and its importance in laboratory animal research. ILAR J. 56, 153-158 (2015).
38. Laukens, D., Brinkman, B.M., Raes, J., De Vos, M. & Vandenabeele, P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol. Rev. 40, 117-132 (2016).
39. Podolsky, D.K., Gerken, G., Eyking, A. & Cario, E. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137, 209-220 (2009).
40. Kilkenny, C., Browne, W.J., Cuthill, I.C., Emerson, M. & Altman, D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).
41. Becker, C. et al. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 54, 950-954 (2005).
42. Vowinkel, T., Kalogeris, T.J., Mori, M., Krieglstein, C.F. & Granger, D.N. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig. Dis. Sci. 49, 556-564 (2004).
43. Tseng, J.C. & Kung, A.L. In vivo imaging of inflammatory phagocytes. Chem. Biol. 19, 1199-1209 (2012).
44. Van den Broeck, W., Derore, A. & Simoens, P. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J. Immunol. Methods 312, 12-19 (2006).
45. Strober, W. Appendix 3B Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. http://dx.doi.org/10.1002/0471142735.ima03bs21 (2001).
46. Yu, Y.R. et al. A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues. PLoS One 11, e0150606 (2016).
47. Amsen, D., de Visser, K.E. & Town, T. Approaches to determine expression of inflammatory cytokines. Methods Mol. Biol. 511, 107-142 (2009).
48. Moolenbeek, C. & Ruitenberg, E.J. The 'Swiss roll': a simple technique for histological studies of the rodent intestine. Lab. Anim. 15, 57-59 (1981).
49. Cardiff, R.D., Miller, C.H. & Munn, R.J. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb. Protoc. 2014, 655-658 (2014).
50. Wirtz, S., Billmeier, U., McHedlidze, T., Blumberg, R.S. & Neurath, M.F. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141, 1875-1886 (2011).
51. Becker, C., Fantini, M.C. & Neurath, M.F. High resolution colonoscopy in live mice. Nat. Protoc. 1, 2900-2904 (2006).
52. Erben, U. et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int. J. Clin. Exp. Pathol. 7, 4557-4576 (2014).
53. Pfeiffer, C.J. & Qiu, B.S. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J. Pharm. Pharmacol. 47, 827-832 (1995).
54. Weigmann, B. et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2, 2307-2311 (2007).
55. Edgar, R.C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996-998 (2013).
56. Huse, S.M. et al. VAMPS: a website for visualization and analysis of microbial population structures. BMC Bioinformatics 15, 41 (2014).
57. Cooper, H.S., Murthy, S.N., Shah, R.S. & Sedergran, D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249 (1993).